AU2020903196A0 - Salts and crystals - Google Patents

Salts and crystals

Info

Publication number
AU2020903196A0
AU2020903196A0 AU2020903196A AU2020903196A AU2020903196A0 AU 2020903196 A0 AU2020903196 A0 AU 2020903196A0 AU 2020903196 A AU2020903196 A AU 2020903196A AU 2020903196 A AU2020903196 A AU 2020903196A AU 2020903196 A0 AU2020903196 A0 AU 2020903196A0
Authority
AU
Australia
Prior art keywords
crystals
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020903196A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kinoxis Therapeutics Pty Ltd
Original Assignee
Kinoxis Therapeutics Pty Ltd
Filing date
Publication date
Application filed by Kinoxis Therapeutics Pty Ltd filed Critical Kinoxis Therapeutics Pty Ltd
Publication of AU2020903196A0 publication Critical patent/AU2020903196A0/en
Priority to AU2021336662A priority Critical patent/AU2021336662A1/en
Priority to PCT/AU2021/051033 priority patent/WO2022047548A1/en
Priority to EP21863128.1A priority patent/EP4211138A1/en
Priority to KR1020237011768A priority patent/KR20230066050A/en
Priority to MX2023002774A priority patent/MX2023002774A/en
Priority to CN202180075241.0A priority patent/CN116745293A/en
Priority to IL301181A priority patent/IL301181A/en
Priority to JP2023515354A priority patent/JP2023540587A/en
Priority to CA3191811A priority patent/CA3191811A1/en
Abandoned legal-status Critical Current

Links

AU2020903196A 2020-09-07 2020-09-07 Salts and crystals Abandoned AU2020903196A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
AU2021336662A AU2021336662A1 (en) 2020-09-07 2021-09-07 Salts and crystals
PCT/AU2021/051033 WO2022047548A1 (en) 2020-09-07 2021-09-07 Salts and crystals
EP21863128.1A EP4211138A1 (en) 2020-09-07 2021-09-07 Salts and crystals
KR1020237011768A KR20230066050A (en) 2020-09-07 2021-09-07 salts and crystals
MX2023002774A MX2023002774A (en) 2020-09-07 2021-09-07 Salts and crystals.
CN202180075241.0A CN116745293A (en) 2020-09-07 2021-09-07 Salts and crystals
IL301181A IL301181A (en) 2020-09-07 2021-09-07 Salts and crystals
JP2023515354A JP2023540587A (en) 2020-09-07 2021-09-07 salt and crystals
CA3191811A CA3191811A1 (en) 2020-09-07 2021-09-07 Salts and crystals

Publications (1)

Publication Number Publication Date
AU2020903196A0 true AU2020903196A0 (en) 2020-09-17

Family

ID=

Similar Documents

Publication Publication Date Title
EP3628007A4 (en) Novel salts and crystals
EP3919483A4 (en) Benzopyridone heterocyclic compound and use thereof
EP3746075A4 (en) Gcn2 inhibitors and uses thereof
EP3436455A4 (en) Novel salts and crystals
EP3746071A4 (en) Gcn2 inhibitors and uses thereof
EP3969455A4 (en) Amorphous and crystalline forms of relugolix
EP3508621A4 (en) Gallium arsenide crystalline body and gallium arsenide crystal substrate
EP3763713A4 (en) Crystal form and salt form of pyridoimidazole compound and preparation method therefor
EP4011881A4 (en) Crystalline form of atr inhibitor and use thereof
EP3841092A4 (en) Crystalline form of compound and uses thereof in medicine
ZA202200964B (en) Salts of a compound, crystal forms of the salts and preparation method and use thereof
EP3981771A4 (en) Synthesis method of furoimidazopyridine compound, crystal form of furoimidazopyridine compound, and crystal form of salt thereof
EP3915638A4 (en) Heterocyclic compound and use thereof
EP3849964A4 (en) Crystalline forms of a quinazole compound and its hydrochloride salts
EP3725791A4 (en) Salt serving as akt inhibitor and crystal thereof
EP3919493A4 (en) Crystal of diarylthiohydantoin compound
AU2020903196A0 (en) Salts and crystals
EP3733186A4 (en) Novel dihydro-quinazolinone compound or pharmacologically acceptable salt thereof, and cell growth inhibitor
EP3837268A4 (en) Salts of compounds and crystals thereof
EP3936189A4 (en) Salt of pentacyclic compound and crystals thereof
EP3947361A4 (en) A salt and crystal form of a fak inhibitor
EP3992192A4 (en) Dominant salt forms of pyrimidine derivatives, and crystal forms thereof
IL308750A (en) Novel salts and crystals
EP4017857A4 (en) Mettl16 inhibitors and uses thereof
EP3854797A4 (en) Crystal form of tri-cycle compound and application thereof